Prescryptive & Ilant Health Expand Employer Access To Obesity Care & GLP-1 Therapies

Prescryptive, a health care technology company, and Ilant Health, an obesity and cardiometabolic health company, announced a collaboration to expand employer access to GLP-1 therapies and obesity care services.

The collaboration combines Prescryptive’s direct-to-market platform with Ilant’s Center of Excellence (COE) model. Ilant provides obesity care services, including clinical prescribing, lifestyle support, and outcome tracking. Employers can offer GLP-1 and obesity therapies with clinical oversight and defined performance metrics.

Employers participating in Ilant’s obesity management programs have reported the following outcomes:

Therapy retention: Over 90% of enrolled members remained on therapy at six . . .